Human Milk Sample Composition in Israeli Mothers and Correlation With Their Diet
NCT ID: NCT02596295
Last Updated: 2018-02-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
120 participants
OBSERVATIONAL
2015-10-31
2017-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study in Lactating Mothers and Their Newborns to Analyse the Composition of Human Milk
NCT05979532
Influence of Bovine Milk Consumption on Hormonal Profile in Males
NCT02931006
Relationship Between Nutritional Consumption of Breastfeeding Mothers and Breast Milk Composition During Lactation
NCT07036094
At-the-Breast vs. Expressed Human Milk: Genesis of Infant Nutrition (BEGIN)
NCT06691932
Developing Remote Human Milk Collection as a Novel Technique for Transcriptome Sequencing
NCT07118852
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
ECOLOGIC_OR_COMMUNITY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Mothers for term infants
Lactating mothers
No interventions assigned to this group
Mothers for preterm infants
Lactating mothers
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
Infants:
Any congenital abnormality, chromosomal disorder or severe disease which could interfere with the study conduct and assessment.
15 Years
55 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Enzymotec
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yael Lifshitz, PhD
Role: STUDY_DIRECTOR
Employee
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Meir Hospital
Kfar Saba, State, Israel
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HM001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.